Ask AI
ProCE Banner Activity

Considerations for PrEP for People Who Inject Drugs

Clinical Thought
Adherence and accessibility are critical to improving uptake and effectiveness of PrEP for PWID.

Released: April 15, 2022

Continue Activity View Activity

Share

Supporters

Supported by an educational grant from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Karine Lacombe, MD, PhD

Professor of Medicine
Sorbonne University
Head of Infectious Diseases Unit
St Antoine Hospital, AP-HP
Paris, France

Karine Lacombe, MD, PhD, has disclosed that she has received consulting fees from Gilead Sciences, GlaxoSmithKline, Janssen, and MSD.